XBiotech Inc. financial data

Symbol
XBIT on Nasdaq
Location
5217 Winnebago Lane, Austin, TX
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.76K % -68.2%
Debt-to-equity 6.15 % +154%
Return On Equity -16.5 % -38.2%
Return On Assets -15.6 % -33.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5M shares +0.09%
Common Stock, Shares, Outstanding 30.5M shares +0.09%
Entity Public Float 140M USD +5.77%
Common Stock, Value, Issued 272M USD +1.15%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares +0.06%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 38.2M USD +19.9%
General and Administrative Expense 4.77M USD -2.26%
Operating Income (Loss) -42.9M USD -22.8%
Nonoperating Income (Expense) 8.13M USD -14.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -34.8M USD -37%
Income Tax Expense (Benefit) 136K USD -95.6%
Net Income (Loss) Attributable to Parent -35M USD -23.2%
Earnings Per Share, Basic -1.15 USD/shares -22.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 189M USD +31.5%
Accounts Receivable, after Allowance for Credit Loss, Current 870K USD
Assets, Current 191M USD -9.01%
Deferred Income Tax Assets, Net 772K USD +20.2%
Property, Plant and Equipment, Net 24.9M USD -2.76%
Assets 216M USD -8.33%
Accounts Payable, Current 1.7M USD -6.17%
Employee-related Liabilities, Current 562K USD +14.9%
Accrued Liabilities, Current 5.35M USD +103%
Liabilities, Current 17.1M USD +285%
Accrued Income Taxes, Noncurrent 1.72M USD +5.92%
Deferred Income Tax Liabilities, Net 0 USD -100%
Liabilities 18.9M USD +210%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -75.3M USD -86.9%
Stockholders' Equity Attributable to Parent 197M USD -14.1%
Liabilities and Equity 216M USD -8.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.2M USD -49.8%
Net Cash Provided by (Used in) Financing Activities 10.1M USD
Net Cash Provided by (Used in) Investing Activities -255K USD -4150%
Common Stock, Shares, Issued 30.4M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.02M USD
Deferred Tax Assets, Valuation Allowance 17.6M USD +56.6%
Deferred Tax Assets, Gross 18.2M USD +40.1%
Depreciation 432K USD -2.48%
Payments to Acquire Property, Plant, and Equipment 255K USD +4150%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -35.4M USD -16.2%
Deferred Tax Assets, Operating Loss Carryforwards 1.29M USD
Unrecognized Tax Benefits 2.97M USD +3.81%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 628K USD -63.5%
Share-based Payment Arrangement, Expense 2.4M USD -36.5%